Celestica CEO sells 66,056 shares under 10b5-1 plan
Celestica Inc. Chief Executive Officer Robert Mionis reported open-market sales of 66,056 common shares on June 15, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Celestica Inc. Chief Executive Officer Robert Mionis reported open-market sales of 66,056 common shares on June 15, 2026. The transactions, carried out by Mionis 2026 GRAT Number Three, were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 11, 2026.
The shares were sold in multiple trades at prices reported around $394–$414 per share, with each line showing a specific weighted-average price. After these sales, Mionis 2026 GRAT Number Three held 134,328 common shares, while separate filings show indirect holdings of 210,445 shares in Mionis 2026 GRAT Number One, 145,565 shares in Mionis 2026 GRAT Number Two, and a direct holding of 453,697 common shares.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Shares | 1,420 | $394.58 | $560K |
| Sale | Common Shares | 2,983 | $395.92 | $1.18M |
| Sale | Common Shares | 2,668 | $396.83 | $1.06M |
| Sale | Common Shares | 10,350 | $397.92 | $4.12M |
| Sale | Common Shares | 11,245 | $398.86 | $4.49M |
| Sale | Common Shares | 10,730 | $399.68 | $4.29M |
| Sale | Common Shares | 6,374 | $400.87 | $2.56M |
| Sale | Common Shares | 11,118 | $401.94 | $4.47M |
| Sale | Common Shares | 6,786 | $402.77 | $2.73M |
| Sale | Common Shares | 280 | $403.75 | $113K |
| Sale | Common Shares | 444 | $406.46 | $180K |
| Sale | Common Shares | 160 | $407.48 | $65K |
| Sale | Common Shares | 80 | $409.26 | $33K |
| Sale | Common Shares | 80 | $410.22 | $33K |
| Sale | Common Shares | 80 | $412.01 | $33K |
| Sale | Common Shares | 1,178 | $412.94 | $486K |
| Sale | Common Shares | 80 | $413.68 | $33K |
| holding | Common Shares | -- | -- | -- |
| holding | Common Shares | -- | -- | -- |
| holding | Common Shares | -- | -- | -- |
Footnotes (17)
- F1. This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 11, 2026.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $394.31-$395.30, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3. On March 10, 2026, the Reporting Person contributed 200,384 shares of the Issuer's common shares to Mionis 2026 GRAT Number Three, which contribution was exempt from Section 16 pursuant to Rule 16a-13 under the Exchange Act.
- F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $395.32-$396.25, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $396.40-$397.29, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $397.46-$398.30, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $398.31-$399.30, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $399.31-$400.215, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $400.34-$401.30, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $401.38-$402.29, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $402.31-$403.30, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F12. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $403.45-$404.00, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F13. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $406.345-$406.755, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F14. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $407.44-$407.51, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F15. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $412.33-$413.26, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F16. On February 6, 2026, the Reporting Person contributed 210,445 shares of the Issuer's common shares to Mionis 2026 GRAT Number One, which contribution was exempt from Section 16 pursuant to Rule 16a-13 under the Exchange Act.
- F17. On February 19, 2026, the Reporting Person contributed 145,565 shares of the Issuer's common shares to Mionis 2026 GRAT Number Two, which contribution was exempt from Section 16 pursuant to Rule 16a-13 under the Exchange Act.
Key Figures
Key Terms
Rule 10b5-1 plan regulatory
GRAT financial
Section 16 regulatory
weighted average price financial
Rule 16a-13 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Celestica (CLS) report for CEO Robert Mionis?
AI-generated analysis. How Rhea-AI works. Not financial advice.